サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768823

接続ドラッグデリバリー機器の世界市場

Connected Drug Delivery Devices

出版日
ページ情報
英文 172 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
接続ドラッグデリバリー機器の世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 172 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

接続ドラッグデリバリー機器の世界市場は2030年までに255億米ドルに達する見込み

2024年に79億米ドルと推定される接続ドラッグデリバリー機器の世界市場は、2024年から2030年にかけてCAGR 21.5%で成長し、2030年には255億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるスタンドアロン・コンポーネント＆ソフトウェアは、CAGR 20.2％を記録し、分析期間終了時には148億米ドルに達すると予測されます。集積デバイス分野の成長率は、分析期間中CAGR 23.4％と推定されます。

米国市場は21億米ドル、中国はCAGR20.4％で成長予測

米国の接続ドラッグデリバリー機器市場は、2024年に21億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに39億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは20.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ19.3％と18.4％と予測されています。欧州では、ドイツがCAGR約14.7%で成長すると予測されています。

世界の接続ドラッグデリバリー機器市場- 主要動向と促進要因のまとめ

接続ドラッグデリバリー機器とは何か、なぜヘルスケアに変革をもたらすのか？

接続ドラッグデリバリー機器とは、薬物投与のモニタリングと管理を可能にするセンサーと接続機能を備えた医療機器です。これらのデバイスには、スマート吸入器、インスリンペン、ウェアラブル注射器、自動注射器などが含まれ、使用データをヘルスケアプロバイダーにリアルタイムで送信し、患者のアドヒアランスや治療効果に関する洞察を提供します。接続ドラッグデリバリー機器は、服薬コンプライアンスを向上させ、個人に合わせた投与ガイダンスを提供し、患者の遠隔監視を可能にします。患者とヘルスケアプロバイダー間のシームレスなコミュニケーションを促進することで、これらのデバイスはヘルスケア提供に変革をもたらし、患者が最も効果的でパーソナライズされたケアを受けられるようにします。

接続ドラッグデリバリー機器の重要性は、糖尿病、喘息、関節リウマチなどの慢性疾患の管理に不可欠な、患者の関与と処方されたレジメンのアドヒアランスを高める能力にあります。これらの機器によって収集されたデータは、治療パターンや患者の行動に関する実用的な洞察をヘルスケアプロバイダーに提供し、アドヒアランスの問題が発生した場合に積極的な介入を可能にします。さらに、コネクテッドデバイスが提供するリアルタイムのフィードバックは、患者の服薬管理をより効果的にし、服用漏れや合併症の可能性のリスクを低減します。ヘルスケアシステムがますます患者中心のデータ駆動型治療に重点を置くようになる中、接続ドラッグデリバリー機器は治療成績の向上に重要な役割を果たしています。

技術の進歩は接続ドラッグデリバリー機器をどのように向上させていますか？

技術の進歩は、接続ドラッグデリバリー機器の機能とアプリケーションを急速に向上させ、より正確で、患者にやさしく、多用途なものにしています。Bluetooth、Wi-Fi、近距離無線通信（NFC）技術の統合により、デバイスからモバイルアプリやクラウドプラットフォームへのシームレスなデータ転送が可能になり、医療従事者がリアルタイムでデータを分析し、アクセスできるようになりました。AIや機械学習アルゴリズムも接続ドラッグデリバリー機器を変革し、パーソナライズされた投薬スケジュールを可能にし、患者の行動に基づいてアドヒアランスパターンを予測することで、全体的な治療効果を高めています。

ウェアラブル技術の開発により、スマートインスリンポンプやウェアラブル注射器など、より快適で目立たないデバイスが開発され、日常生活への支障を最小限に抑えて投薬できるようになりました。さらに、モバイルアプリとの統合により、患者はリマインダー、投与量の追跡、教育リソースを受け取ることができ、これにより服薬アドヒアランスが促進され、患者が自分の状態を積極的に管理できるようになります。バッテリー寿命の向上と小型化により、これらのデバイスはより携帯しやすく、使いやすくなり、活動的で移動の多い患者のニーズに応えられるようになりました。これらの技術的進歩により、接続ドラッグデリバリー機器は現代ヘルスケアに不可欠な存在となり、患者のアドヒアランス、利便性、治療の成功を向上させています。

患者ケアにおける接続ドラッグデリバリー機器の主な用途は？

接続ドラッグデリバリー機器は、一貫した服薬アドヒアランスが不可欠な慢性疾患管理アプリケーションに幅広く使用されています。糖尿病管理では、スマートインスリンペンや持続グルコースモニター（CGM）により、患者はインスリン投与量を正確に管理・追跡することができ、個人に合わせた投与をサポートするデータを提供し、合併症のリスクを軽減します。喘息や慢性閉塞性肺疾患（COPD）のような呼吸器疾患では、接続された吸入器が吸入器の使用に関するリマインダーやフィードバックを提供し、患者が処方されたレジメンを遵守するのを支援するとともに、医療提供者が遠隔で状態のコントロールを監視できるようにします。

腫瘍学の分野では、ウェアラブル注射器によって化学療法薬のデリバリーが制御できるため、頻繁な通院の必要性が減り、患者は自宅で治療を管理できるようになります。関節リウマチの治療では、コネクテッド自動注射器が使用され、患者が処方されたとおりに薬を受け取れるようにし、医療提供者が治療計画を最適化するために使用できるデータを提供しています。臨床試験では、接続ドラッグデリバリー機器は正確な投与情報を取得することでデータの正確性を向上させ、患者の自己申告への依存を減らし、試験の完全性を高めます。これらのアプリケーションは、接続ドラッグデリバリー機器が疾病管理から臨床研究まで、患者ケアの様々な側面をサポートする多用途性を強調しています。

接続ドラッグデリバリー機器市場の成長を促進する要因は？

接続ドラッグデリバリー機器市場の成長は、慢性疾患の増加、コネクテッドヘルスケアの技術進歩、患者のアドヒアランス重視の高まりなど、いくつかの要因によってもたらされます。糖尿病、喘息、心血管疾患などの慢性疾患の有病率が上昇する中、接続ドラッグデリバリー機器は、アドヒアランスを向上させ、効果的な治療結果を保証する役割を果たすため、高い需要があります。AI、モバイルアプリの統合、リアルタイムのデータ分析などの技術的進歩により、これらのデバイスの機能が強化され、より使いやすく、患者のケアを遠隔で管理するのに有効になっています。

遠隔医療や遠隔患者モニタリングの受け入れが拡大しているため、ヘルスケアプロバイダーは服薬アドヒアランスを追跡し、必要な場合に介入できるようになり、通院回数が減り、患者エンゲージメントが向上しています。また、個別化医療への注目が高まるにつれ、カスタマイズ可能な投与スケジュールやリアルタイムのモニタリングを提供する機器への需要も高まっており、オーダーメイドの治療ソリューションを求める傾向に合致しています。さらに、製薬会社やヘルスケアプロバイダーは、臨床試験における接続ドラッグデリバリー機器の利点を認識しており、接続ドラッグデリバリー機器はデータの正確性と患者のコンプライアンスを向上させます。これらの要因が相まって、接続ドラッグデリバリー機器市場の拡大が促進され、デジタル化が進むヘルスケアの状況において、ヘルスケアの提供と患者の転帰を向上させる役割を担っています。

セグメント

提供（スタンドアロンコンポーネント＆ソフトウェア、統合デバイス）;投与経路（非経口投与、吸入投与）;アプリケーション（糖尿病管理アプリケーション、COPDアプリケーション、喘息アプリケーション、その他のアプリケーション）

調査対象企業の例

  • Adherium Limited
  • Aterica
  • Biocorp
  • FindAir
  • Merck KGaA
  • Phillips Medisize
  • Propeller Health
  • Proteus Digital Health
  • West Pharmaceutical Services, Inc.

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP21524

Global Connected Drug Delivery Devices Market to Reach US$25.5 Billion by 2030

The global market for Connected Drug Delivery Devices estimated at US$7.9 Billion in the year 2024, is expected to reach US$25.5 Billion by 2030, growing at a CAGR of 21.5% over the analysis period 2024-2030. Standalone Components & Software, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$14.8 Billion by the end of the analysis period. Growth in the Integrated Devices segment is estimated at 23.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 20.4% CAGR

The Connected Drug Delivery Devices market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 20.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.3% and 18.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global Connected Drug Delivery Devices Market - Key Trends & Drivers Summarized

What Are Connected Drug Delivery Devices, and Why Are They Transforming Healthcare?

Connected drug delivery devices are medical devices equipped with sensors and connectivity features that allow for the monitoring and management of drug administration. These devices include smart inhalers, insulin pens, wearable injectors, and auto-injectors that transmit real-time usage data to healthcare providers, offering insights into patient adherence and treatment efficacy. Connected drug delivery devices improve medication compliance, provide personalized dosage guidance, and enable remote patient monitoring, making them especially valuable in chronic disease management, where adherence to treatment is crucial for health outcomes. By facilitating seamless communication between patients and healthcare providers, these devices are transforming healthcare delivery, ensuring that patients receive the most effective, personalized care.

The significance of connected drug delivery devices lies in their ability to enhance patient engagement and adherence to prescribed regimens, which is vital in managing chronic conditions like diabetes, asthma, and rheumatoid arthritis. The data collected by these devices offers healthcare providers actionable insights into treatment patterns and patient behavior, enabling proactive intervention when adherence issues arise. Additionally, the real-time feedback provided by connected devices helps patients manage their medications more effectively, reducing the risk of missed doses and potential complications. As healthcare systems increasingly focus on patient-centered, data-driven care, connected drug delivery devices play a crucial role in improving treatment outcomes.

How Are Technological Advancements Enhancing Connected Drug Delivery Devices?

Technological advancements are rapidly improving the capabilities and applications of connected drug delivery devices, making them more precise, patient-friendly, and versatile. Integration of Bluetooth, Wi-Fi, and near-field communication (NFC) technologies allows for seamless data transfer from the device to mobile apps and cloud platforms, where data can be analyzed and accessed by healthcare providers in real time. AI and machine learning algorithms are also transforming connected drug delivery devices, enabling personalized medication schedules and predicting adherence patterns based on patient behavior, enhancing the overall treatment efficacy.

Advances in wearable technology have led to the development of more comfortable and discreet devices, such as smart insulin pumps and wearable injectors, that can deliver medication with minimal disruption to daily life. Furthermore, mobile app integration allows patients to receive reminders, dosage tracking, and educational resources, which promotes adherence and empowers patients to manage their conditions actively. Enhanced battery life and miniaturization have made these devices more portable and user-friendly, catering to the needs of active and mobile patients. Together, these technological advancements make connected drug delivery devices an integral part of modern healthcare, improving patient adherence, convenience, and treatment success.

What Are the Key Applications of Connected Drug Delivery Devices Across Patient Care?

Connected drug delivery devices are widely used across a range of chronic disease management applications, where consistent medication adherence is essential. In diabetes management, smart insulin pens and continuous glucose monitors (CGMs) allow patients to administer and track insulin doses accurately, providing data that supports personalized dosing and reduces the risk of complications. For respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), connected inhalers offer reminders and feedback on inhaler usage, helping patients adhere to prescribed regimens and enabling providers to monitor control of the condition remotely.

In the field of oncology, wearable injectors allow for controlled delivery of chemotherapy drugs, reducing the need for frequent hospital visits and enabling patients to manage their treatment at home. Connected auto-injectors are used in rheumatoid arthritis treatment, ensuring patients receive their medications as prescribed and providing data that healthcare providers can use to optimize treatment plans. In clinical trials, connected drug delivery devices improve data accuracy by capturing precise dosing information, reducing reliance on patient self-reporting and enhancing trial integrity. These applications underscore the versatility of connected drug delivery devices in supporting various aspects of patient care, from disease management to clinical research.

What Factors Are Driving Growth in the Connected Drug Delivery Devices Market?

The growth in the connected drug delivery devices market is driven by several factors, including the rise of chronic diseases, technological advancements in connected healthcare, and increasing emphasis on patient adherence. With the prevalence of chronic conditions like diabetes, asthma, and cardiovascular disease on the rise, connected drug delivery devices are in high demand for their role in improving adherence and ensuring effective treatment outcomes. Technological advancements, such as AI, mobile app integration, and real-time data analytics, are enhancing the capabilities of these devices, making them more user-friendly and effective in managing patient care remotely.

The growing acceptance of telemedicine and remote patient monitoring has further boosted adoption, as connected drug delivery devices allow healthcare providers to track adherence and intervene when necessary, reducing hospital visits and improving patient engagement. Increased focus on personalized medicine has also spurred demand for devices that offer customizable dosing schedules and real-time monitoring, aligning with the trend toward tailored treatment solutions. Moreover, pharmaceutical companies and healthcare providers are recognizing the benefits of connected drug delivery devices in clinical trials, where they improve data accuracy and patient compliance. Together, these factors are driving the expansion of the connected drug delivery devices market, supporting its role in enhancing healthcare delivery and patient outcomes in an increasingly digital healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Connected Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Standalone Components & Software, Integrated Devices); Administration Route (Parenteral Administration, Inhalational Administration); Application (Diabetes Management Application, COPD Application, Asthma Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Adherium Limited
  • Aterica
  • Biocorp
  • FindAir
  • Merck KGaA
  • Phillips Medisize
  • Propeller Health
  • Proteus Digital Health
  • West Pharmaceutical Services, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Connected Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Drives Demand for Connected Drug Delivery Devices That Enable Remote Patient Monitoring
    • Growth in Home Healthcare Expands Market for Connected Drug Delivery Devices That Offer Self-Administration and Real-Time Feedback
    • Rising Focus on Personalized Medicine Propels Demand for Connected Devices That Provide Customizable Dosing and Monitoring
    • Advancements in IoT Technology Strengthen Business Case for Connected Drug Delivery Devices with Real-Time Data Sharing
    • Growing Demand for Patient Adherence Solutions Drives Adoption of Connected Drug Delivery Devices with Reminder and Tracking Features
    • Expansion of Digital Health Solutions Supports Market for Connected Devices That Integrate with Mobile Apps and Health Portals
    • Increasing Focus on Reducing Healthcare Costs Drives Demand for Connected Drug Delivery Devices That Minimize Hospital Visits
    • Rising Use of AI in Healthcare Expands Market for Connected Devices with Predictive Analytics and Personalized Care Features
    • Increasing Need for Continuous Glucose Monitoring Expands Market for Connected Drug Delivery Devices in Diabetes Management
    • Growing Focus on Remote Clinical Trials Drives Demand for Connected Drug Delivery Devices That Enable Real-Time Data Collection
    • Rising Investment in Smart Inhalers and Connected Injectors Propels Growth in Asthma and Respiratory Disease Management
    • Increasing Adoption of Wearable Health Tech Expands Applications of Connected Drug Delivery Devices in Chronic Disease Management
    • Growth in Preventive Healthcare Expands Market for Connected Devices That Monitor Patient Metrics and Predict Health Risks
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Standalone Components & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Standalone Components & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Integrated Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Integrated Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Inhalational Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Inhalational Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Diabetes Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Diabetes Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for COPD Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for COPD Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Connected Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION